Drug news
EU approves Ilesto 7 (Biotronik) for patients with Heart Failure
The Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) series, from Biotronik, has received CE approval in the EU for patients with Heart Failure who require resynchronisation therapy. The Ilesto 7 series includes one of the world�s smallest ICDs and features ProMRI technology, which enables access to potentially life-saving MR scans. The Ilesto offers patients and physicians the greatest longevity available� up to 11.5 years for the single chamber ICD and 7.5 years for the CRT-D device. In addition the devices� optimized shape and the new DF4 connector provide a number of important benefits for both physicians and patients. Patients also benefit from secure remote monitoring via Biotronik Home Monitoring.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins